SKIN PENETRATION AND METABOLISM - COMPARATIVE-EVALUATION OF SKIN EQUIVALENT, CELL-CULTURE, AND HUMAN SKIN

被引:10
作者
ADEMOLA, JI
BLOOM, E
MACZULAK, AE
MAIBACH, HI
机构
[1] Department of Dermatology School of Medicine, University of California, San Francisco, CA
来源
JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY | 1993年 / 12卷 / 02期
关键词
D O I
10.3109/15569529309036255
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Using an organotypic model of human skin, living skin equivalent (LSE) and its homogenate, monolayer cell culture, and human skin, we have studied the simultaneous transport and metabolic fate of two compounds. The LSE was maintained in an assay culture medium. When the model compounds were applied to LSE at dosages of 9.0 +/- 1.2 mug/cm2, the transport of salicylic acid through human skin was 0.12 +/- 0.1 mug/cm2/hr. Salicylic acid flux was 5.6-fold greater in LSE than in human skin. Shorter lag time of absorption was observed in LSE (approximately 1.5 hr) than in human skin (7-9 hr). Percutaneous transport across LSE was accompanied by metabolism of the compounds and there were quantitative and qualitative similarities between the metabolites produced by the LSE and human skin. When compounds were added to homogenates (LSE or skin) and to human cell cultures, the activities of the LSE and human fractions were similar. Data from the present study demonstrate that although LSE is more permeable than human skin, the artificial skin is a potentially valuable model for skin pharmacologic studies.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 18 条
[1]   CUTANEOUS METABOLISM OF THEOPHYLLINE BY THE HUMAN SKIN [J].
ADEMOLA, JI ;
WESTER, RC ;
MAIBACH, HI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (03) :310-314
[2]  
ADEMOLA JI, IN PRESS J PHARM SCI
[3]   LIVING TISSUE FORMED INVITRO AND ACCEPTED AS SKIN-EQUIVALENT TISSUE OF FULL THICKNESS [J].
BELL, E ;
EHRLICH, HP ;
BUTTLE, DJ ;
NAKATSUJI, T .
SCIENCE, 1981, 211 (4486) :1052-1054
[4]   THE LIVING SKIN EQUIVALENT - ITS MANUFACTURE, ITS ORGANOTYPIC PROPERTIES AND ITS RESPONSES TO IRRITANTS [J].
BELL, E ;
PARENTEAU, N ;
GAY, R ;
NOLTE, C ;
KEMP, P ;
BILBO, P ;
EKSTEIN, B ;
JOHNSON, E .
TOXICOLOGY IN VITRO, 1991, 5 (5-6) :591-596
[5]   PRODUCTION OF A TISSUE-LIKE STRUCTURE BY CONTRACTION OF COLLAGEN LATTICES BY HUMAN-FIBROBLASTS OF DIFFERENT PROLIFERATIVE POTENTIAL INVITRO [J].
BELL, E ;
IVARSSON, B ;
MERRILL, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (03) :1274-1278
[6]  
BELL E, 1989, PHARM APPLICATIONS C, P131
[7]  
Bell E., 1984, Patent US, Patent No. 4485096
[8]  
BELL E, IN PRESS J BIOMECHAN
[9]   EXTENT OF CUTANEOUS METABOLISM DURING PERCUTANEOUS-ABSORPTION OF XENOBIOTICS [J].
BRONAUGH, RL ;
STEWART, RF ;
STORM, JE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 99 (03) :534-543
[10]  
BRONAUGH RL, 1985, PERCUTANEOUS ABSORPT, V6, P267